NasdaqGS - Delayed Quote USD

Materialise NV (MTLS)

Compare
7.45 -0.20 (-2.61%)
At close: December 20 at 4:00:02 PM EST
7.57 +0.12 (+1.61%)
After hours: December 20 at 5:56:55 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Brigitte de Vet-Veithen Chief Executive Officer -- -- 1972
Mr. Koen Berges Chief Financial Officer -- -- --
Mr. Johan Pauwels Chief Operating Officer -- -- 1968
Mr. Bart Van der Schueren Chief Strategy & Technology Officer and Executive VP -- -- 1968
Ms. Carla Van Steenbergen Director of Corporate Affairs, VP, Compliance Officer & Secretary -- -- 1977
Ms. Conny Hooghe Global HR Director -- -- 1967
Mr. Jurgen Laudus Executive Vice President of Manufacturing -- -- 1979
Mr. Udo Eberlein Executive Vice President of Software -- -- --

Materialise NV

Technologielaan 15
Leuven, 3001
Belgium
32 1 639 66 11 https://www.materialise.com
Sector: 
Technology
Industry: 
Software—Application
Full Time Employees: 
2,437

Description

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Corporate Governance

Materialise NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 24, 2024 at 12:00 AM UTC

Materialise NV Earnings Date

Recent Events

October 24, 2024 at 12:30 PM UTC

Q3 2024 Earnings Call

Related Tickers